《半日速報》恆指半日收報23,833點 升87點; 恆生科技指數半日收報5,654點 升28點 藥明生物升逾6% 匯控、遠洋集團創新高
恆指半日收23,833點,升87點或0.4%。恆生科技指數報5,654點,升28點或0.5%。國指升43點或0.5%,報8,408點。
活躍重磅股表現:
美團(03690.HK) 收210.6元,上升1.9%;
騰訊(00700.HK) 收460.6元,上升1.6%;
建行(00939.HK) 收5.84元,上升1.6%;
阿裏巴巴(09988.HK) 收125.8元,下跌1.4%;
友邦(01299.HK) 收78.9元,下跌1.4%;
平安(02318.HK) 收61.25元,下跌1.1%;
港交所(00388.HK) 收457.6元,下跌0.1%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收87.8元,上升6.2%;
信達生物(01801.HK) 收45.2元,上升5.6%;
融創中國(01918.HK) 收12.58元,上升4.7%;
中國海外發展(00688.HK) 收22.9元,上升3.6%;
碧桂園服務(06098.HK) 收45.25元,上升3.4%;
阿裏健康(00241.HK) 收7.19元,上升3.3%;
長實集團(01113.HK) 收51.05元,上升3.1%;
匯控(00005.HK) 收51.85元,上升0.3%,創新高;
異動綜合中小型股:
祥生控股集團(02599.HK) 收1.28元,上升17.4%;
遠洋集團(03377.HK) 收2.03元,上升2.5%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.